Justin Stebbing
#61,129
Most Influential Person Now
Researcher
Justin Stebbing's AcademicInfluence.com Rankings
Justin Stebbingphilosophy Degrees
Philosophy
#6044
World Rank
#9007
Historical Rank
Logic
#3235
World Rank
#4362
Historical Rank
Download Badge
Philosophy
Justin Stebbing's Degrees
- Bachelors Biology University of Oxford
- PhD Cancer Biology University of Oxford
Similar Degrees You Can Earn
Why Is Justin Stebbing Influential?
(Suggest an Edit or Addition)According to Wikipedia, Justin Stebbing is editor-in-chief of Nature’s cancer journal Oncogene, a visiting Professor of Cancer Medicine and Oncology at Imperial College, London and a Professor of Biomedical Sciences at ARU, Cambridge. In October 2022 he joined the Phoenix Hospital Group in London to provide medical services to patients for the management of cancer, in person and remotely. He specialises in a range of solid malignancies including difficult cases with few conventional options and has published over 700 papers, the majority regarding new therapeutic and translational approaches including use of immunotherapies in clinical trials, many in the world's best journals.
Justin Stebbing's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Baricitinib as potential treatment for 2019-nCoV acute respiratory disease (2020) (1118)
- COVID-19: combining antiviral and anti-inflammatory treatments (2020) (874)
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. (2014) (684)
- Highly active antiretroviral therapy and the incidence of non-AIDS-defining cancers in people with HIV infection. (2009) (343)
- The estrogen receptor-α-induced microRNA signature regulates itself and its transcriptional response (2009) (329)
- Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma. (2005) (269)
- The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. (2017) (248)
- Mechanism of baricitinib supports artificial intelligence‐predicted testing in COVID‐19 patients (2020) (206)
- A Meta-analysis of Transient Elastography for the Detection of Hepatic Fibrosis (2010) (203)
- HIV-Associated Anal Cancer: Has Highly Active Antiretroviral Therapy Reduced the Incidence or Improved the Outcome? (2004) (197)
- Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence (2019) (197)
- British HIV Association guidelines for HIV‐associated malignancies 2008 (2008) (191)
- Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors (2017) (187)
- A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma (2003) (185)
- Where does HIV live? (2004) (181)
- Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. (2012) (180)
- Mutation Analysis of Cell-Free DNA and Single Circulating Tumor Cells in Metastatic Breast Cancer Patients with High Circulating Tumor Cell Counts (2016) (176)
- A novel and validated prognostic index in hepatocellular carcinoma: the inflammation based index (IBI). (2012) (174)
- Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis (2018) (173)
- The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper. (2019) (172)
- Brief Communication: Rituximab in HIV-Associated Multicentric Castleman Disease (2007) (171)
- Influence of Plasma Processing on Recovery and Analysis of Circulating Nucleic Acids (2013) (169)
- Renal Dysfunction With Tenofovir Disoproxil Fumarate-Containing Highly Active Antiretroviral Therapy Regimens Is Not Observed More Frequently: A Cohort and Case-Control Study (2004) (167)
- AN OPEN-LABEL STUDY OF TENOFOVIR IN HIV-1 AND HEPATITIS B VIRUS CO-INFECTED INDIVIDUALS (2002) (161)
- HIV/AIDS: epidemiology, pathophysiology, and treatment of Kaposi sarcoma-associated herpesvirus disease: Kaposi sarcoma, primary effusion lymphoma, and multicentric Castleman disease. (2008) (155)
- Noninvasive detection of activating estrogen receptor 1 (ESR1) mutations in estrogen receptor-positive metastatic breast cancer. (2015) (153)
- The role of immune suppression and HHV-8 in the increasing incidence of HIV-associated multicentric Castleman's disease. (2009) (151)
- MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression. (2014) (151)
- The value of anal cytology and human papillomavirus typing in the detection of anal intraepithelial neoplasia: a review of cases from an anoscopy clinic (2005) (149)
- Patient-derived xenografts for individualized care in advanced sarcoma (2014) (148)
- JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality (2020) (147)
- Prognostic performance of inflammation-based prognostic indices in primary operable non-small cell lung cancer (2014) (136)
- Clinical Features and Outcome in HIV-Associated Multicentric Castleman's Disease. (2011) (134)
- The efficacy and safety of weekly vinorelbine in relapsed malignant pleural mesothelioma. (2009) (133)
- Kinome screening for regulators of the estrogen receptor identifies LMTK3 as a new therapeutic target in breast cancer (2011) (129)
- Herceptin (trastuzamab) in advanced breast cancer. (2000) (129)
- MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors (2012) (124)
- Characterization of the cytokine storm reflects hyperinflammatory endothelial dysfunction in COVID-19 (2020) (122)
- A Prognostic Index for Systemic AIDS-Related Non-Hodgkin Lymphoma Treated in the Era of Highly Active Antiretroviral Therapy (2005) (121)
- Serum interleukin (IL)‐1, IL‐2, sIL‐2Ra, IL‐6 and thrombopoietin levels in patients with chronic myeloproliferative diseases (2005) (121)
- Extracellular vesicles swarm the cancer microenvironment: from tumor–stroma communication to drug intervention (2017) (120)
- Is asthma protective against COVID‐19? (2020) (120)
- Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer (2016) (119)
- miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts (2013) (119)
- Clinical Characteristics and Outcomes of COVID-19–Infected Cancer Patients: A Systematic Review and Meta-Analysis (2020) (119)
- An open-label assessment of TMC 125—a new, next-generation NNRTI, for 7 days in HIV-1 infected individuals with NNRTI resistance (2003) (119)
- Endocrine Resistance in Hormone Receptor Positive Breast Cancer–From Mechanism to Therapy (2019) (114)
- Protease inhibitors potentiate chemotherapy-induced neutropenia. (2004) (113)
- The treatment of advanced renal cell cancer with high-dose oral thalidomide (2001) (109)
- A prognostic index for AIDS-associated Kaposi's sarcoma in the era of highly active antiretroviral therapy (2006) (104)
- Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma. (2004) (101)
- Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden (2018) (99)
- Why does cytotoxic chemotherapy cure only some cancers? (2009) (98)
- Deep sequencing of small RNAs identifies canonical and non-canonical miRNA and endogenous siRNAs in mammalian somatic tissues (2013) (98)
- SARS-CoV-2 (COVID-19) superspreader events (2020) (97)
- Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. (2000) (96)
- Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis (2015) (95)
- The effects of trastuzumab on the CD4+CD25+FoxP3+ and CD4+IL17A+ T-cell axis in patients with breast cancer (2009) (95)
- Mammosphere formation assay from human breast cancer tissues and cell lines. (2015) (94)
- Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study (2021) (93)
- A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia (2007) (92)
- microRNAs with prognostic significance in pancreatic ductal adenocarcinoma: A meta-analysis. (2015) (91)
- Unique localization of circulating tumor cells in patients with hepatic metastases. (2009) (90)
- Final results of a multicenter phase II clinical trial evaluating the activity of single-agent lapatinib in patients with HER2-negative metastatic breast cancer and HER2-positive circulating tumor cells. A proof-of-concept study (2012) (90)
- Kinases as targets in the treatment of solid tumors. (2010) (88)
- miR‐515‐5p controls cancer cell migration through MARK4 regulation (2016) (87)
- CT-P6 compared with reference trastuzumab for HER2-positive breast cancer: a randomised, double-blind, active-controlled, phase 3 equivalence trial. (2017) (87)
- HIV, hepatitis B and hepatitis C coinfection in Kenya (2008) (86)
- The regulatory roles of phosphatases in cancer (2014) (83)
- Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment (2008) (82)
- TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression (2018) (82)
- Reduced dissemination of circulating tumor cells with no-touch isolation surgical technique in patients with pancreatic cancer. (2014) (79)
- Novel tumour suppressive protein encoded by circular RNA, circ-SHPRH, in glioblastomas (2018) (79)
- [18F]-3′Deoxy-3′-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel (2011) (78)
- Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID‐A study (2021) (77)
- Emerging Roles of Competing Endogenous RNAs in Cancer: Insights from the Regulation of PTEN (2013) (74)
- Diagnosis and management of phyllodes tumour of the breast: experience of 33 cases at a specialist centre. (1995) (71)
- The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer. (2012) (71)
- Next Generation Sequencing of Circulating Cell-Free DNA for Evaluating Mutations and Gene Amplification in Metastatic Breast Cancer. (2017) (71)
- Downregulation of microRNA-515-5p by the estrogen receptor modulates sphingosine kinase 1 and breast cancer cell proliferation. (2013) (70)
- Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer: Implications for immunotherapy (2016) (69)
- Antibodies to selected minor target antigens in patients with anti‐neutrophil cytoplasmic antibodies (ANCA) (2007) (68)
- FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman’s disease (2009) (68)
- Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer (2014) (67)
- Molecular basis of 5-fluorouracil-related toxicity: lessons from clinical practice. (2014) (66)
- Measurements of EGFR expression on circulating tumor cells are reproducible over time in metastatic breast cancer patients. (2009) (66)
- Protein kinases as targets for cancer treatment. (2007) (65)
- Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease. (2011) (64)
- Clinical significance of circulating tumor cells. (2007) (64)
- Impact of antiretroviral choice on hypercholesterolaemia events: the role of the nucleoside reverse transcriptase inhibitor backbone (2005) (62)
- The efficacy of percutaneous vertebroplasty for vertebral metastases associated with solid malignancies. (2009) (61)
- Antigen presentation and the role of dendritic cells in HIV (2004) (59)
- Human immunodeficiency virus-associated primary lung cancer in the era of highly active antiretroviral therapy: a multi-institutional collaboration. (2010) (59)
- Altered Tissue 3′-Deoxy-3′-[18F]Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography (2009) (57)
- The prolyl‐hydroxylase EGLN3 and not EGLN1 is inactivated by methylation in plasma cell neoplasia (2010) (56)
- Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. (2003) (55)
- The heat-shock protein receptor CD91 is up-regulated in monocytes of HIV-1-infected "true" long-term nonprogressors. (2003) (55)
- Kaposi's Sarcoma-Associated Herpesvirus Cytotoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes (2003) (54)
- A review of the ethnic differences in breast cancer. (2006) (53)
- Image‐guided thermosensitive liposomes for focused ultrasound drug delivery: Using NIRF‐labelled lipids and topotecan to visualise the effects of hyperthermia in tumours (2018) (53)
- Integrated molecular analysis to investigate the role of microRNAs in pancreatic tumour growth and progression (2015) (53)
- Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma (2018) (52)
- Fanconi syndrome and lactic acidosis associated with stavudine and lamivudine therapy (2008) (52)
- Management of complex colonic polyps in the English Bowel Cancer Screening Programme (2013) (52)
- IDH mutations in tumorigenesis and their potential role as novel therapeutic targets. (2013) (52)
- Quantification of Pancreatic Cancer Proteome and Phosphorylome: Indicates Molecular Events Likely Contributing to Cancer and Activity of Drug Targets (2014) (52)
- Cytokine changes during rituximab therapy in HIV-associated multicentric Castleman disease. (2009) (52)
- TP53 regulates miRNA association with AGO2 to remodel the miRNA–mRNA interaction network (2016) (52)
- Multicenter study of human immunodeficiency virus-related germ cell tumors. (2003) (51)
- Serum Molecular Signatures of Weight Change during Early Breast Cancer Chemotherapy (2009) (51)
- Circulating sphingosine-1-phosphate and erythrocyte sphingosine kinase-1 activity as novel biomarkers for early prostate cancer detection (2012) (50)
- Highly active antiretroviral therapy and human immunodeficiency virus-associated primary cerebral lymphoma. (2006) (49)
- Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway (2014) (49)
- Reproducibility of [11C]Choline-Positron Emission Tomography and Effect of Trastuzumab (2010) (49)
- Baricitinib for COVID-19: a suitable treatment? – Authors' reply (2020) (48)
- Percutaneous irreversible electroporation with systemic treatment for locally advanced pancreatic adenocarcinoma. (2018) (48)
- A trial of caspofungin salvage treatment in PCP pneumonia (2010) (47)
- [11C]Choline Positron Emission Tomography in Estrogen Receptor–Positive Breast Cancer (2009) (47)
- The clades of HIV: their origins and clinical significance. (2003) (46)
- A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumour responses to chemotherapy. (2012) (46)
- Efficacy and safety of first‐ or second‐line irinotecan, cisplatin, and mitomycin in mesothelioma (2007) (45)
- Claudin-1 as a promoter of EMT in hepatocellular carcinoma (2013) (45)
- Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer (2011) (45)
- Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy. (2003) (44)
- Impact of PD-L1 expression, driver mutations and clinical characteristics on survival after anti-PD-1/PD-L1 immunotherapy versus chemotherapy in non-small-cell lung cancer: A meta-analysis of randomized trials (2017) (44)
- LMTK3 is implicated in endocrine resistance via multiple signaling pathways (2013) (44)
- Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression–free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy (2011) (43)
- Disease-associated dendritic cells respond to disease-specific antigens through the common heat shock protein receptor. (2003) (43)
- Test, test, test for COVID-19 antibodies: the importance of sensitivity, specificity and predictive powers (2020) (42)
- Clinical outcome in resistant HIV-2 infection treated with raltegravir and maraviroc. (2010) (42)
- Outcomes from elective colorectal cancer surgery during the SARS‐CoV‐2 pandemic (2020) (42)
- Hepatitis C virus infection in HIV type 1-infected individuals does not accelerate a decrease in the CD4+ cell count but does increase the likelihood of AIDS-defining events. (2005) (41)
- LMTK3 expression in breast cancer: association with tumor phenotype and clinical outcome (2012) (41)
- The germline of the malaria mosquito produces abundant miRNAs, endo-siRNAs, piRNAs and 29-nt small RNAs (2015) (41)
- The frequency and reasons for antiretroviral switching with specific antiretroviral associations: the SWITCH study. (2010) (40)
- Should cervical cancer be an acquired immunodeficiency syndrome-defining cancer? (2006) (40)
- Lack of response of anal intra-epithelial neoplasia to highly active antiretroviral therapy. (2003) (40)
- Loss of miR-126 is crucial to pancreatic cancer progression (2012) (39)
- The role of pseudokinases in cancer. (2012) (39)
- The risks and incidence of K65R and L74V mutations and subsequent virologic responses. (2008) (39)
- CNS penetration of potential anti-COVID-19 drugs (2020) (38)
- The Clinico-Pathologic Role of MicroRNAs miR-9 and miR-151-5p in Breast Cancer Metastasis (2012) (38)
- The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma. (2004) (38)
- Patient-derived xenograft models—the future of personalised cancer treatment (2020) (38)
- Immunologic recovery in survivors following chemotherapy for AIDS-related non-Hodgkin lymphoma. (2008) (37)
- The dual function of KSR1: a pseudokinase and beyond. (2013) (37)
- Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping (2019) (37)
- Breast Cancer Treatment and Adverse Cardiac Events: What Are the Molecular Mechanisms? (2012) (36)
- Rituximab as retreatment for rituximab pretreated HIV-associated multicentric Castleman disease. (2007) (36)
- Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case–control study (2010) (36)
- Von Hippel-Lindau methylation status in patients with multiple myeloma: a potential predictive factor for the development of bone disease. (2009) (36)
- Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individuals. (2005) (35)
- Prospective cohort study showing changes in the monthly incidence of Pneumocystis carinii pneumonia (2003) (35)
- Breast cancer (metastatic). (2007) (35)
- The Kinase LMTK3 Promotes Invasion in Breast Cancer Through GRB2-Mediated Induction of Integrin β1 (2014) (35)
- How does HAART lead to the resolution of Kaposi's sarcoma? (2003) (34)
- Circulating tumor cells and plasma DNA analysis in patients with indeterminate early or metastatic breast cancer. (2011) (34)
- Resolution of AIDS-related Castleman's Disease with Anti-CD20 Monoclonal Antibodies is Associated with Declining IL-6 and TNF-α Levels (2004) (34)
- Adherence to trizivir and tenofovir as a simplified salvage regimen is associated with suppression of viraemia and a decreased cholesterol. (2005) (34)
- Combined PKC and MEK inhibition for treating metastatic uveal melanoma (2014) (34)
- Epigenetics: an emerging technology in the diagnosis and treatment of cancer. (2006) (34)
- Kinetic filtering of [18F]Fluorothymidine in positron emission tomography studies (2010) (33)
- The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention (2018) (33)
- Pegylated liposomal doxorubicin (Caelyx) in recurrent ovarian cancer. (2002) (32)
- ‘Being there' for women with metastatic breast cancer: a pan-European patient survey (2012) (32)
- An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma. (2012) (32)
- Pulmonary manifestations of ulcerative colitis mimicking Wegener's granulomatosis. (1999) (31)
- Insights into the molecular biology and sero-epidemiology of Kaposi's sarcoma (2003) (31)
- Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer (2016) (31)
- Transcriptome-level microarray expression profiling implicates IGF-1 and Wnt signalling dysregulation in the pathogenesis of thyroid-associated orbitopathy (2012) (31)
- The Efficacy of Lapatinib in Metastatic Breast Cancer with HER2 Non-Amplified Primary Tumors and EGFR Positive Circulating Tumor Cells: A Proof-Of-Concept Study (2013) (31)
- The use of temozolomide in recurrent malignant gliomas. (2002) (31)
- The p53 miRNA interactome and its potential role in the cancer clinic. (2013) (31)
- A microRNA meta-signature for pancreatic ductal adenocarcinoma (2014) (31)
- A randomised trial comparing the pharmacokinetics and safety of the biosimilar CT-P6 with reference trastuzumab (2018) (31)
- Circulating free DNA in the management of breast cancer. (2014) (30)
- Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. (2009) (30)
- The impact of adjuvant chemotherapy timing on overall survival following colorectal cancer resection. (2015) (30)
- Insulin-like growth factor receptor polymorphism defines clinical outcome in estrogen receptor-positive breast cancer patients treated with tamoxifen (2013) (30)
- The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus‐associated multi‐centric Castleman's disease (2008) (30)
- MicroRNAs associated with small bowel neuroendocrine tumours and their metastases (2016) (29)
- Dynamic changes of the inflammation‐based index predict mortality following chemoembolisation for hepatocellular carcinoma: a prospective study (2014) (29)
- HIV‐associated multicentric Castleman's disease (2008) (29)
- Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis (2015) (29)
- Sphingosine kinase 1 contributes to leptin-induced STAT3 phosphorylation through IL-6/gp130 transactivation in oestrogen receptor-negative breast cancer (2014) (29)
- The efficacy of ritonavir in the prevention of AIDS‐related Kaposi's sarcoma (2004) (28)
- Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer (2016) (28)
- Cell-derived extracellular vesicles can be used as a biomarker reservoir for glioblastoma tumor subtyping (2019) (28)
- Hepatitis C infection is not associated with systemic HIV‐associated non‐hodgkin's lymphoma: A cohort study (2005) (28)
- LMTK3 confers chemo-resistance in breast cancer (2018) (28)
- MicroRNAs associated with small bowel neuroendocrine tumours and their metastases. (2016) (28)
- Highly active anti‐retroviral therapy (HAART)‐induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV‐induced mortality (2006) (28)
- MSLN Gene Silencing Has an Anti-Malignant Effect on Cell Lines Overexpressing Mesothelin Deriving from Malignant Pleural Mesothelioma (2014) (28)
- Gene of the month: Axl (2016) (28)
- A randomized study comparing a three- and four-drug HAART regimen in first-line therapy (QUAD study). (2005) (28)
- CK1δ modulates the transcriptional activity of ERα via AIB1 in an estrogen-dependent manner and regulates ERα–AIB1 interactions (2009) (27)
- A phase II study using a topoisomerase I-based approach in patients with multiply relapsed germ-cell tumours. (2007) (27)
- A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib (2020) (27)
- LMTK3 escapes tumour suppressor miRNAs via sequestration of DDX5. (2016) (27)
- Schizophrenia does not adversely affect the treatment of women with breast cancer: a cohort study. (2010) (26)
- Biological basis of [11C]choline-positron emission tomography in patients with breast cancer: comparison with [18F]fluorothymidine positron emission tomography (2011) (26)
- Nadir B cell counts are significantly correlated with the risk of Kaposi's sarcoma (2004) (26)
- Outcome of patients with HIV-related germ cell tumours: a case–control study (2004) (26)
- What can oncologists learn from HIV? (2003) (25)
- The clinical significance of radiologically detected silent pulmonary nodules in early breast cancer. (2008) (25)
- Expression of the common heat‐shock protein receptor CD91 is increased on monocytes of exposed yet HIV‐1‐seronegative subjects (2005) (25)
- The Tumor-Suppressor Protein OPCML Potentiates Anti–EGFR- and Anti–HER2-Targeted Therapy in HER2-Positive Ovarian and Breast Cancer (2017) (25)
- The relationship between ethnicity, social deprivation and late presentation of colorectal cancer. (2017) (25)
- Avoidable delay in the management of carcinoma of the right colon. (1995) (25)
- Role of SMAD proteins in colitis-associated cancer: from known to the unknown (2018) (25)
- Nivolumab-induced fulminant diabetic ketoacidosis followed by thyroiditis (2018) (25)
- The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours (2006) (25)
- microRNAs as markers of survival and chemoresistance in pancreatic ductal adenocarcinoma (2011) (25)
- LMTK3 Represses Tumor Suppressor-like Genes through Chromatin Remodeling in Breast Cancer. (2015) (24)
- Spontaneous splenic haematoma in a multiple myeloma patient receiving pegfilgrastim support. (2006) (24)
- Magnetic resonance imaging and spectroscopy of the brain in HIV disease. (2008) (24)
- Milk thistle: early seeds of potential. (2013) (24)
- Expansion of CD8+ Cytotoxic T Cells in vitro and in vivo Using MHC Class I Tetramers (2007) (24)
- Primary esophageal carcinoma in the era of highly active antiretroviral therapy. (2010) (24)
- Angiosarcoma and Dialysis-related Arteriovenous Fistulae: A Comprehensive Review. (2016) (23)
- Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation (2019) (23)
- DUSP16 is an epigenetically regulated determinant of JNK signalling in Burkitt's lymphoma (2010) (23)
- Lack of intra‐patient strain variability during infection with Kaposi's sarcoma‐associated herpesvirus (2001) (23)
- Two-Stage Resection for Bilobar Colorectal Liver Metastases: R0 Resection Is the Key (2011) (23)
- A randomized trial to investigate the recycling of stavudine and didanosine with and without hydroxyurea in salvage therapy (RESTART). (2004) (22)
- The Effect of Statins on HIV Rebound and Blips (2005) (22)
- Peritoneal disease in breast cancer: a specific entity with an extremely poor prognosis. (2009) (22)
- Paclitaxel for AIDS-associated Kaposi’s sarcoma (2005) (22)
- Monitoring early response to taxane therapy in advanced breast cancer with circulating tumor cells and [(18)F] 3´-deoxy-3´-fluorothymidine PET: a pilot study. (2012) (22)
- AIDS-associated Kaposi's sarcoma associated with a low viral load and a high CD4 cell count. (2008) (22)
- New insights into the immunology and evolution of HIV (2003) (22)
- Curative resection for low rectal adenocarcinoma: abdomino‐perineal vs anterior resection (2006) (21)
- MicroRNAs in the cancer clinic. (2013) (21)
- MicroRNA-23b regulates cellular architecture and impairs motogenic and invasive phenotypes during cancer progression (2013) (21)
- Peritoneal disease in breast cancer: A specific entity with an extremely poor prognosis. (2009) (21)
- Hyperthermia in cancer: is it coming of age? (2014) (21)
- Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial (2021) (21)
- Assessment of the efficacy of total lymphocyte counts as predictors of AIDS defining infections in HIV-1 infected people (2005) (21)
- ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation (2016) (21)
- Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? (2006) (21)
- A meta-analysis comparing responses of Asian versus non-Asian cancer patients to PD-1 and PD-L1 inhibitor-based therapy (2020) (21)
- HIV and AIDS in the People's Republic of China: a collaborative review (2003) (20)
- The common heat shock protein receptor CD91 is up‐regulated on monocytes of advanced melanoma slow progressors (2004) (20)
- Imaging of cellular proliferation in liver metastasis by [18F]fluorothymidine positron emission tomography: effect of therapy (2012) (20)
- EGFR-Mutated Squamous Cell Lung Cancer and Its Association With Outcomes (2021) (20)
- The role of TP53 in miRNA loading onto AGO2 and in remodelling the miRNA–mRNA interaction network (2015) (20)
- Circulating peripheral blood mononuclear cells exhibit altered miRNA expression patterns in pancreatic cancer (2013) (20)
- A comparison of the CD4 response to antiretroviral regimens in patients commencing therapy with low CD4 counts. (2004) (20)
- Managing patients with cancer in the COVID-19 era (2020) (20)
- Hide and seek: tell-tale signs of breast cancer lurking in the blood (2013) (20)
- A validated prognostic index predicting response to dexamethasone and diethylstilbestrol in castrate‐resistant prostate cancer (2010) (20)
- The emerging harm of antioxidants in carcinogenesis. (2012) (19)
- Use of mathematical models to understand anticancer drug delivery and its effect on solid tumors. (2011) (19)
- Towards a clinical use of miRNAs in pancreatic cancer biopsies (2013) (19)
- SILAC-based phosphoproteomics reveals an inhibitory role of KSR1 in p53 transcriptional activity via modulation of DBC1 (2013) (19)
- Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States (2013) (19)
- Baricitinib reduces 30‐day mortality in older adults with moderate‐to‐severe COVID‐19 pneumonia (2021) (19)
- Prospective validation of microRNA signatures for detecting pancreatic malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies (2013) (19)
- All for CD91 and CD91 for all. (2003) (19)
- A Pan-Cancer Analysis of SMARCA4 Alterations in Human Cancers (2021) (19)
- The evidence-based use of induction chemotherapy in Breast Cancer (2001) (19)
- Circulating MicroRNAs in Small-bowel Neuroendocrine Tumors: A Potential Tool for Diagnosis and Assessment of Effectiveness of Surgical Resection. (2019) (19)
- Non-AIDS-defining cancers (2009) (19)
- An open-label study of lapatinib in women with HER-2-negative early breast cancer: the lapatinib pre-surgical study (LPS study). (2013) (18)
- Mutation analysis of cell-free DNA and single circulating tumor cells in metastatic breast cancer patients with high CTC counts (2016) (18)
- Efficacy and safety of CT-P6 versus reference trastuzumab in HER2-positive early breast cancer: updated results of a randomised phase 3 trial (2019) (18)
- An overview of drug development for metastatic breast cancer. (2012) (18)
- Non-Hodgkin’s lymphoma and the CNS: prophylaxis and therapy in immunocompetent and HIV-positive individuals (2006) (18)
- GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours (2007) (18)
- C-reactive protein and vascular cell adhesion molecule-1 as markers of severity in sickle cell disease. (2006) (18)
- The diagnostic yield of stool analysis in 525 HIV-1-infected individuals. (2003) (17)
- Breast cancer (non-metastatic). (2005) (17)
- PIK3Cδ expression by fibroblasts promotes triple-negative breast cancer progression. (2020) (17)
- The evolution of coreceptor tropism in HIV-infected patients interrupting suppressive antiretroviral therapy. (2011) (17)
- Whole Genome Sequence Analysis Suggests Intratumoral Heterogeneity in Dissemination of Breast Cancer to Lymph Nodes (2014) (17)
- Clinical and pathological overlap in nonsteroidal anti-inflammatory drug-related small bowel diaphragm disease and the neuromuscular and vascular hamartoma of the small bowel. (2001) (17)
- Colorectal cancer in HIV positive individuals: the immunological effects of treatment. (2011) (17)
- PARP inhibitors in BRCA1-/BRCA2-associated and triple-negative breast cancers. (2010) (17)
- Hepatocellular cancer in HIV-infected individuals: tomorrow’s problem? (2006) (17)
- Characterization of the Tyrosine Kinase-Regulated Proteome in Breast Cancer by Combined use of RNA interference (RNAi) and Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) Quantitative Proteomics* (2015) (17)
- Potential antiretroviral drug interactions with cyclophosphamide, Doxorubicin, and Etoposide. (2005) (16)
- Ethnic variation in breast cancer incidence and outcomes—the debate continues (2014) (16)
- Treatment of primary HIV‐1 infection with nonnucleoside reverse transcriptase inhibitor‐based therapy is effective and well tolerated (2004) (16)
- TAMing resistance to multi-targeted kinase inhibitors through Axl and Met inhibition (2016) (16)
- The phosphorylated membrane estrogen receptor and cytoplasmic signaling and apoptosis proteins in human breast cancer (2008) (16)
- The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. (2006) (16)
- The presence of disseminated tumour cells in the bone marrow is inversely related to circulating free DNA in plasma in breast cancer dormancy (2011) (16)
- LATS2 is a modulator of estrogen receptor alpha. (2013) (16)
- Noncoding RNAs and the control of signalling via nuclear receptor regulation in health and disease. (2015) (16)
- SCIRT lncRNA Restrains Tumorigenesis by Opposing Transcriptional Programs of Tumor-Initiating Cells (2020) (15)
- Ginger: the root of cancer therapy? (2012) (15)
- The collagen prolyl hydroxylases are novel transcriptionally silenced genes in lymphoma (2012) (15)
- Brain metastases associated with germ cell tumors may be treated with chemotherapy alone (2014) (15)
- Current treatment of HIV infection. (2003) (15)
- Circulating tumour cells as more than prognostic markers. (2009) (15)
- Epigenetic changes in gastroenteropancreatic neuroendocrine tumours (2014) (15)
- miRNAs in breast cancer: ready for real time? (2012) (15)
- Pneumonia due to antibiotic resistant Streptococcus pneumoniae and Pseudomonas aeruginosa in the HAART era. (2003) (15)
- Sustained expression of miR-26a promotes chromosomal instability and tumorigenesis through regulation of CHFR (2017) (15)
- Antibody-targeted MHC complex-directed expansion of HIV-1- and KSHV-specific CD8+ lymphocytes: a new approach to therapeutic vaccination. (2004) (15)
- A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study) (2008) (14)
- LBA O-9 Botensilimab, a novel innate/adaptive immune activator, plus balstilimab (anti-PD-1) for metastatic heavily pretreated microsatellite stable colorectal cancer (2022) (14)
- Initiation of adjuvant chemotherapy within 8 weeks of elective colorectal resection improves overall survival regardless of reoperation (2016) (14)
- Blood-based miRNAs as noninvasive diagnostic and surrogative biomarkers in colorectal cancer (2013) (14)
- Natural killer cells are not infected by Kaposi's sarcoma-associated herpesvirus in vivo, and natural killer cell counts do not correlate with the risk of developing Kaposi's sarcoma (2003) (14)
- Serial analysis of circulating tumor cells in metastatic breast cancer receiving first-line chemotherapy. (2020) (14)
- The Nucleoside Backbone Affects Durability of Efavirenz- or Nevirapine-Based Highly Active Antiretroviral Therapy in Antiretroviral-Naive Individuals (2009) (14)
- Stress in the workplace amongst medical professionals. (2007) (14)
- Understanding the Role of Comparative Clinical Studies in the Development of Oncology Biosimilars (2020) (14)
- Breast Cancer in the Setting of HIV (2011) (13)
- Human immunodeficiency virus--associated renal cell carcinoma: a transatlantic case series. (2008) (13)
- Multiple Microaneurysms of the Superior Hemorrhoidal Artery: Unusual Recurrent Massive Rectal Bleeding (2003) (13)
- Serum molecular signatures of weight change during early breast cancer chemotherapy. (2009) (13)
- Lineage-Specific Genes Are Prominent DNA Damage Hotspots during Leukemic Transformation of B Cell Precursors (2017) (13)
- JAK Inhibitors — More Than Just Glucocorticoids (2021) (13)
- KSR1 regulates BRCA1 degradation and inhibits breast cancer growth (2014) (13)
- Aristolochia: the malignant truth. (2013) (13)
- A novel platform for attenuating immune hyperactivity using EXO‐CD24 in COVID‐19 and beyond (2022) (13)
- Distinct miRNA profiles are associated with malignant transformation of pancreatic cystic tumors revealing potential biomarkers for clinical use (2013) (13)
- The structure-function relationship of oncogenic LMTK3 (2020) (13)
- The management of meningeal lymphoma in patients with HIV in the era of HAART: intrathecal depot cytarabine is effective and safe. (2006) (13)
- Melatonin: resetting the clock of cancer progression? (2016) (13)
- Nuts and cancer: where are we now? (2013) (13)
- Incidence of cancer in individuals receiving chronic zopiclone or eszopiclone requires prospective study. (2005) (13)
- The influence of antiretroviral therapy on the QTc interval in an African cohort. (2012) (12)
- Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. (2004) (12)
- Broader implications of a stage-guided stratified therapeutic approach for AIDS-related Kaposi's sarcoma. (2014) (12)
- Secondary amyloidosis associated with giant cell arteritis/polymyalgia rheumatica. (1999) (12)
- No evidence for a polyomavirus association or aetiology in AIDS-associated nonsmall cell lung cancer (2010) (12)
- Comparative pharmacogenomics of antiretroviral and cytotoxic treatments. (2006) (12)
- Proteomic profile of KSR1-regulated signalling in response to genotoxic agents in breast cancer (2015) (12)
- Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic Variation (2017) (12)
- Noncoding RNAs and the control of hormonal signaling via nuclear receptor regulation. (2014) (12)
- The MACC1-SPON2 axis: a new biomarker and therapeutic target in colorectal cancer (2017) (12)
- Crosstalk-induced loss of miR-126 promotes angiogenesis (2014) (12)
- Intramedullary spinal cord metastases in breast cancer are associated with improved longer-term systemic control. (2010) (12)
- Studies on the allostimulatory function of dendritic cells from HCV-HIV-1 co-infected patients (2004) (12)
- Double-blind, randomized phase III study to compare the efficacy and safety of CT-P6, trastuzumab biosimilar candidate versus trastuzumab as neoadjuvant treatment in HER2 positive early breast cancer (EBC). (2017) (12)
- Black cohosh, hot flushes, and breast cancer. (2015) (12)
- The relationship between vitamin D and chemotherapy-induced toxicity – a pilot study (2012) (12)
- HIV-associated Kaposi sarcoma and gender. (2007) (12)
- Single-cell sequencing in cancer research (2016) (12)
- Gene editing in the context of an increasingly complex genome (2018) (11)
- miR-515-5 p controls cancer cell migration through MARK 4 regulation (2016) (11)
- Imaging , Diagnosis , Prognosis [ 18 F ]-3 0 Deoxy-3 0-Fluorothymidine Positron Emission Tomography and Breast Cancer Response to Docetaxel (2011) (11)
- Absence of methylation-dependent transcriptional silencing in TP73 irrespective of the methylation status of the CDKN2A CpG island in plasma cell neoplasia. (2009) (11)
- Abstract S3-01: IMENEO: International MEta-analysis of circulating tumor cell detection in early breast cancer patients treated by NEOadjuvant chemotherapy (2017) (11)
- Epigenetic modifications in AML and MDS. (2010) (11)
- The efficacy of irinotecan, paclitaxel, and oxaliplatin (IPO) in relapsed germ cell tumours with high‐dose chemotherapy as consolidation: a non‐cisplatin‐based induction approach (2016) (11)
- Cryptogenic pseudocirrhosis: a new clinical syndrome of noncirrhotic portal hypertension (unassociated with advanced fibrosis) that can be detected by transient elastography in patients with HIV. (2009) (11)
- Repurposing Fostamatinib to Combat SARS-CoV-2-Induced Acute Lung Injury (2020) (11)
- The preferences and experiences of different bisphosphonate treatments in women with breast cancer (2011) (11)
- Corrigendum: Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer (British Journal of Cancer (2016) 115 (789-796) DOI: 10.1038/bjc.2016.271) (2016) (10)
- Breast cancer (metastatic). (2010) (10)
- Emtricitabine intolerance in treatment-experienced patients switched from lamivudine: a method of assessing toxicity. (2006) (10)
- Lemur tyrosine kinase-3 (LMTK3) in cancer and evolution (2011) (10)
- Gene of the month: NANOG (2015) (10)
- Circulating Tumor DNA Profiling From Breast Cancer Screening Through to Metastatic Disease (2021) (10)
- Targeting ALK Rearrangements in NSCLC: Current State of the Art (2022) (10)
- Efficacy and safety of the trastuzumab biosimilar candidate CT-P6. (2018) (10)
- Role of CYP2D6 testing in selection of endocrine therapy for breast cancer. (2007) (10)
- An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma. (2012) (10)
- Use of antidepressants and risk of cancer in individuals infected with HIV. (2008) (10)
- Thermosensitive Liposome-Mediated Drug Delivery in Chemotherapy: Mathematical Modelling for Spatio–temporal Drug Distribution and Model-Based Optimisation (2019) (9)
- Phase I clinical trial comparing PK and safety of trastuzumab and its biosimilar candidate CT-P6 (2017) (9)
- Long-term efficacy and safety of CT-P6 versus trastuzumab in patients with HER2-positive early breast cancer: final results from a randomized phase III trial (2021) (9)
- Breast cancer, locally advanced and metastatic (2012) (9)
- Recent advances in the systemic management of colorectal cancer. (2006) (9)
- Strategies in functional proteomics: Unveiling the pathways to precision oncology. (2016) (9)
- Clinical utility of circulating tumor cell measurement in the diagnosis of indeterminate lesions of the pancreas. (2010) (9)
- Whole Blood Stem Cell Reinfusion and Escalated Dose Melphalan in Castration-Resistant Prostate Cancer: A Phase 1 Study (2012) (9)
- Targeted cancer therapies: Oral health care implications. (2018) (9)
- The current status of interferon‐α treatment in advanced renal cancer (2001) (9)
- Circulating tumour cells as biomarkers in early breast cancer. (2012) (9)
- Is the detection of circulating tumor cells in locally advanced pancreatic cancer a useful prognostic marker? (2013) (9)
- Nucleic acid sequencing (2019) (9)
- Human NK Cells Develop an Exhaustion Phenotype During Polar Degranulation at the Aspergillus fumigatus Hyphal Synapse (2018) (9)
- Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients? (2018) (9)
- Use of Janus kinase inhibitors in COVID-19: a prospective observational series in 522 individuals (2021) (9)
- Fasting: starving cancer. (2017) (9)
- Phase II trial of irinotecan, cisplatin and mitomycin for relapsed small cell lung cancer (2007) (9)
- Virological failure and subsequent resistance profiles in individuals exposed to atazanavir (2007) (8)
- Exploiting interleukin 6 in multicentric Castleman's disease. (2014) (8)
- Prognostic significance of immune subset measurement in individuals with AIDS-associated Kaposi's sarcoma. (2007) (8)
- Kaposi's sarcoma — an update (2003) (8)
- Kaposi's sarcoma as a model for cancer immunotherapy. (2004) (8)
- Chocolate: delicious beauty or harmful beast? (2013) (8)
- A single centre cohort experience with a new once daily antiretroviral drug (2006) (8)
- Antioxidants and cancer. (2011) (8)
- Cell-free DNA for the detection of pancreatic, liver and upper gastrointestinal cancers: has progress been made? (2013) (8)
- A multicentre cohort experience with double-boosted protease inhibitors. (2009) (8)
- Determination of cut-offs for circulating tumor cell measurement in metastatic cancer (2011) (8)
- Efficacy and Safety of First-Line Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis (2021) (8)
- miR-15b and miR-17 Are Tumor-derived Plasma MicroRNAs Dysregulated in Colorectal Neoplasia. (2015) (8)
- Immunotherapy-Related Cystitis: Case Report and Review of the Literature (2021) (8)
- Ascites and apparent renal failure treated with a Foley catheter (1999) (8)
- The K65R mutation in HIV-1 reverse transcriptase. (2004) (7)
- Use of ezetimibe during HIV infection. (2008) (7)
- Immunogenicity after 6 months of BNT162b2 vaccination in frail or disabled nursing home residents: The COVID‐A Study (2021) (7)
- The Host Control of Lytic and Latent Infection with Human Herpesvirus–8 (2006) (7)
- The clinico-pathologic role of microRNAs miR-9 and miR-151-5p in breast cancer metastasis. (2012) (7)
- Cannabis and cancer: reality or pipe dream? (2015) (7)
- Analysis of BCR–ABL1 tyrosine kinase domain mutational spectra in primitive chronic myeloid leukemia cells suggests a unique mutator phenotype (2010) (7)
- Mistletoe: for cancer or just for Christmas? (2013) (7)
- Clinical utility of resistance testing. (2002) (7)
- Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma. (2005) (7)
- Kaposi Sarcoma : A Model of Oncogenesis 2010 (2009) (7)
- Transorbital brain injuries (2005) (7)
- Targeting tumor–stroma crosstalk: the example of the NT157 inhibitor (2016) (7)
- Activating mutations of GNAS and KRAS in cystic fluid can help detect intraductal papillary mucinous neoplasms of the pancreas (2015) (7)
- Circulating sphingosine-1-phosphate inversely correlates with chemotherapy-induced weight gain during early breast cancer (2010) (7)
- Increased carcinoembryonic antigen (CEA) following neoadjuvant chemotherapy predicts poor prognosis in patients that undergo hepatectomy for liver-only colorectal metastases (2017) (7)
- Bendamustine as a model for the activity of alkylating agents. (2008) (7)
- The role of miR-10b in metastatic pancreatic ductal adenocarcinoma. (2012) (7)
- Aloe vera, a natural cancer soother? (2016) (7)
- The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours (2006) (7)
- Innate and adaptive immunological insights into HIV pathogenesis (2003) (7)
- Stemming the HIV epidemic: prevention and therapy go hand in hand. (2003) (6)
- 152PDDouble-blind, randomized phase III study to compare the efficacy and safety of trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early breast cancer (EBC) (2017) (6)
- Recurrent locally advanced breast cancer: the treatment of chest wall disease with further chemotherapy. (2001) (6)
- Breast cancer (non-metastatic). (2007) (6)
- Garlic: a stake through the heart of cancer? (2016) (6)
- Large bowel perforation associated with capecitabine treatment for breast cancer. (2008) (6)
- Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer (2014) (6)
- The potential significance of adaptive evolution and dimerization in chimpanzee intercellular cell adhesion molecules (ICAMs). (2005) (6)
- Cardiotoxicity and anthracyclines (2008) (6)
- Multiple human papillomavirus types appear to be a feature of anal not cervical intra-epithelial neoplasia. (2003) (6)
- Total pathological complete response versus breast pathological complete response in clinical trials of reference and biosimilar trastuzumab in the neoadjuvant treatment of breast cancer (2018) (6)
- Triple-class antiretroviral agent resistance in a large cohort: prevalence and clinical outcomes. (2008) (6)
- A cell-cycle signature classifier for pan-cancer analysis (2020) (6)
- The current status of interferon-alpha treatment in advanced renal cancer. (2001) (6)
- Cell-free DNA as a biomarker in the context of cancer, viruses, and methylation. (2012) (6)
- Bilateral Posterior Uveitis and Retinal Detachment During Immunotherapy: A Case Report and Literature Review (2020) (6)
- Liquorice: a treatment for all sorts? (2017) (6)
- The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter? (2012) (6)
- Asthma phenotypes, comorbidities, and disease activity in COVID‐19: The need of risk stratification (2020) (6)
- AIDS-associated malignancies. (2006) (6)
- Ginseng: panacea among herbal remedies? (2013) (6)
- The absence of CDKN1C (p57KIP2) promoter methylation in myeloid malignancies also characterizes plasma cell neoplasms (2008) (6)
- Cytokine and adhesion molecule expression evolves between the neutrophilic and lymphocytic phases of viral meningitis. (2010) (6)
- Impact of portal vein embolization on expression of cancer stem cell markers in regenerated liver and colorectal liver metastases (2010) (6)
- What is the intermediate host species of SARS-CoV-2? (2021) (6)
- GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours (2007) (6)
- The relationship between prolonged antiretroviral therapy and cryptogenic liver disease. (2009) (6)
- Trastuzumab: unusual responses and toxicities. (2009) (6)
- Sports balls as potential SARS-CoV-2 transmission vectors (2020) (6)
- Point-of-care SARS-CoV-2 serological assays for enhanced case finding in a UK inpatient population (2021) (6)
- A distinct inflammatory marker pattern in patients with aromatase inhibitor (AI)-induced musculoskeletal symptoms. (2009) (6)
- LMTK3 polymorphism in patients with metastatic colon cancer. (2012) (6)
- Investigating miRNA-mRNA regulatory networks using crosslinking immunoprecipitation methods for biomarker and target discovery in cancer (2016) (6)
- The need for multidisciplinarity in specialist training to optimize future patient care (2017) (5)
- ATG 9 A loss confers resistance to trastuzumab via c-Cbl mediated Her 2 degradation (2017) (5)
- The anti‐tumor effects of human immunodeficiency virus protease inhibitors: Ready for real time? (2011) (5)
- Virus host interactions (2003) (5)
- Spontaneous antibodies against Engrailed‐2 (EN2) protein in patients with prostate cancer (2014) (5)
- Epidermal growth factor receptor status in early stage breast cancer is associated with cellular proliferation but not cross-talk (2011) (5)
- Turmeric: a spice for life? (2016) (5)
- Cancer vaccines: Clinical development challenges and proposed regulatory approaches for patient access to promising treatments (2008) (5)
- Cardiac metastasis from a myxoid liposarcoma. (2001) (5)
- Epstein-Barr virus in Burkitt's lymphoma: the missing link. (2009) (5)
- What Is the Best Drug to Treat COVID-19? The Need for Randomized Controlled Trials (2020) (5)
- PDGF-R inhibition induces glioblastoma cell differentiation via DUSP1/p38MAPK signalling (2022) (5)
- Cetuximab in the first-line therapy of metastatic colorectal carcinoma: not so CRYSTAL clear. (2008) (5)
- HIV and hepatitis B: a review. (2003) (5)
- LMTK 3 confers chemo-resistance in breast cancer (2018) (5)
- The genomics of new drugs in sickle cell disease. (2006) (5)
- Rare tumors: an eye on the future. (2015) (4)
- MicroRNAs associated with small bowel neuroendocrine tumors and their metastases. (2016) (4)
- Defining a prognostic molecular profile for ductal adenocarcinoma of the pancreas highlights known key signaling pathways (2012) (4)
- Clinical development of CT-P6 in HER2 positive breast cancer (2019) (4)
- CK 1 d modulates the transcriptional activity of ER a via AIB 1 in an estrogen-dependent manner and regulates ER a – AIB 1 interactions (2009) (4)
- Retinoblastoma protein determines aggressiveness in triple-negative breast cancer (2012) (4)
- 543P Neoadjuvant MRx0518 treatment is associated with significant gene and metagene signature changes in solid tumours (2021) (4)
- The role of CD91 and heat shock proteins in psoriasis (2005) (4)
- The impact of circulating tumor cells (CTCs) detection in metastatic breast cancer (MBC): Implications of “indolent” stage IV disease (Stage IVindolent). (2018) (4)
- [ 11 C]Choline Positron Emission Tomography in Estrogen Receptor – Positive Breast Cancer (2009) (4)
- Association of gender-related tumor recurrence with a polymorphic variant of LMTK3 in stage II and III colon cancer. (2012) (4)
- Integrated analysis of miRNA and mRNA profiles enables target acquisition in human cancers (2012) (4)
- Host pharmacogenetics in the treatment of HIV and cancer. (2006) (4)
- Bevacizumab and surgery: what is the real risk? (2009) (4)
- Model-Based Inference of Recombination Hotspots in a Highly, Variable Oncogene (2004) (4)
- Breast cancer (non-metastatic). (2006) (4)
- Outcome in AIDS-Related Systemic Non-Hodgkin Lymphoma and Leptomeningeal Disease Is Not Predicted by a CT Brain Scan (2007) (4)
- Epirubicin dose and sequential hormonal therapy-Mature results of the HMFEC randomised phase III trial in premenopausal patients with node positive early breast cancer. (2016) (4)
- Purple toes in a patient with end-stage rheumatoid arthritis. (1999) (4)
- Identification of an immune gene-associated prognostic signature in patients with bladder cancer (2022) (4)
- The rationale and development of new drugs to treat HIV infection. (2005) (4)
- Programmed cell death (PD-1) ligands expression in gastro-entero-pancreatic neuroendocrine tumours (GEP-NETs): relationship with angiogenesis and clinical outcome. (2016) (4)
- Rights theory in a specific healthcare context: “Speaking ill of the dead” (2007) (4)
- 3-year follow-up of a phase III trial comparing the efficacy and safety of neoadjuvant and adjuvant trastuzumab and its biosimilar CT-P6 in HER2 positive early breast cancer (EBC) (2019) (4)
- Lessons for HIV from Tuskegee. (2004) (4)
- Spatially resolved profiling of colorectal cancer lipid biochemistry via DESI imaging mass spectrometry to reveal morphology-dependent alterations in fatty acid metabolism. (2016) (4)
- Mutational landscapes of normal breast during age and pregnancy determine cancer risk (2020) (3)
- SSB1/SSB2 Proteins Safeguard B Cell Development by Protecting the Genomes of B Cell Precursors (2019) (3)
- The AI-Assisted Identification and Clinical Efficacy of Baricitinib in the Treatment of COVID-19 (2022) (3)
- Atypical metastases from squamous cell cancers (2002) (3)
- Positioning pemetrexed in the treatment of ovarian cancer. (2009) (3)
- 27PFive year survival in patients with metastatic melanoma receiving IMM-101 (2015) (3)
- Re-evaluating the efficacy of axillary ultrasound in the detection of nodal metastasis and its impact on clinical practice. (2011) (3)
- Germ-cell tumors. (2007) (3)
- Is there a role for intravenous iron therapy in patients undergoing colorectal cancer resection? (2012) (3)
- The Emergence of Baricitinib: A Story of Tortoises Versus Hares (2020) (3)
- Author Correction: TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression (2018) (3)
- New biomarkers in breast cancer: microRNAs and leptins--where are we now? (2007) (3)
- Small cell lung cancer as a cause of acute renal failure secondary to bilateral renal infiltration. (2000) (3)
- Model-Based Inference of Recombination Hotspots in a Highly Variable Oncogene (2004) (3)
- The prognostic role of circulating tumor cells in heavily pretreated individuals with a low life expectancy. (2014) (3)
- Reducing transmission of SARS-CoV-2 with intranasal prophylaxis (2020) (3)
- Novel immunotherapeutic drugs for the treatment of lung cancer (2021) (3)
- Proteome-wide dataset supporting functional study of tyrosine kinases in breast cancer (2016) (3)
- First-Line Treatment Options for PD-L1–Negative Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis (2021) (3)
- Baricitinib as the treatment of choice for hospitalised individuals with COVID-19 (2022) (3)
- Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plans (2018) (3)
- Cancer stem cells--therapeutic targeting or therapy? (2013) (3)
- Abstract PD6-5: Pooled analysis of circulating tumor cells in metastatic breast cancer: Findings from 1944 individual patients data (2013) (3)
- Usefulness of Measuring microRNAs in Bile and Plasma for Pancreatic Ductal Adenocarcinoma Diagnosis (2015) (3)
- Significance of Variation Within HIV, EBV, and KSHV Subtypes (2006) (3)
- LMTK3 inhibition affects microtubule stability (2021) (3)
- Cytotoxic-free treatment designs: time to resistance (2007) (3)
- FLEX data, KRAS and ERCC1 testing in oncology. (2008) (3)
- The potential role of cyclooxygenase-2 (COX-2) during early breast cancer therapy. (2011) (2)
- The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas (2018) (2)
- Risk Factors for ICU Admission, Mechanical Ventilation and Mortality in Hospitalized Patients with COVID-19 in Hubei, China. (2020) (2)
- Coffee: the science and art of moderation. (2012) (2)
- Tumor Volume Analysis and Tumor Doubling. (2009) (2)
- Uncaria tomentosa, the cat's whiskers or claws? (2014) (2)
- Heat shock protein-receptor-based pharmacogenomics: the search for new cancer antigens. (2007) (2)
- Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors (2018) (2)
- Autoimmune hepatitis caused by Brucella: causal or a mere association? (2003) (2)
- Outcomes in unresectable and locally advanced resected cholangiocarcinoma (2011) (2)
- Recombination Does Not Occur in Newly Identified Diverged Oceanic Picornaviruses (2004) (2)
- Clinical Characteristics and Risk Factors for Myocardial Injury and Arrhythmia in COVID-19 patients (2020) (2)
- Reply to S.E. Krown et al. (2014) (2)
- The HVTN 503/Phambili study: efficacy is always the issue. (2011) (2)
- Abstract P5-20-14: Cardiotoxicity in 1 year of treatment with reference trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early stage breast cancer (EBC) patients (2018) (2)
- P4-12-13: A Multi-Center Randomized Controlled Double Blind Trial Assessing the Effect of Acupuncture in Reducing Musculoskeletal Symptoms in Breast Cancer Patients Taking Aromatase Inhibitors: First Interim Analysis. (2011) (2)
- Genetic variants of kinase suppressors of Ras (KSR1) to predict survival in patients with ERα-positive advanced breast cancer (2014) (2)
- Intra-tumoral heterogeneity in the expression of programmed-death (PD) ligands in isogeneic primary and metastatic lung cancer (LC): Implications for immunotherapy. (2016) (2)
- Ayurveda: alternative or complementary? (2012) (2)
- Progression-free versus overall survival and adequate powering in randomised studies. (2008) (2)
- A metabolic phenotyping approach to understanding relationships between metabolic syndrome and breast tumor responses to chemotherapy. (2011) (2)
- Communication with the cancer patient (2008) (2)
- Decoding Metastatic Colorectal Cancer to Improve Clinical Decision Making. (2019) (2)
- Preventing relapse in melanoma (2000) (2)
- ANTIRETROVIRAL TREATMENT REGIMENS AND IMMUNE PARAMETERS IN THE PREVENTION OF SYSTEMIC AIDS-RELATED NHL (2004) (2)
- Investigating the benefits of molecular profiling of advanced non-small cell lung cancer tumors to guide treatments (2018) (2)
- Mouse clinical trials of pancreatic cancer: Integration of PDX models with genomics to improve patient outcomes to chemotherapeutics (2016) (2)
- The Use of Transdermal Estrogen in Castrate-resistant, Steroid-refractory Prostate Cancer. (2019) (2)
- Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (2017) (2)
- The pharmacoeconomics of spiralling cancer drug costs - is there a viable solution? (2011) (2)
- Lymphoid and histiocytic proliferations in HIV-positive patients: problems in diagnosis. (2009) (2)
- The efficacy of percutaneous vertebroplasty for palliation of pain in vertebral metastases associated with solid malignancies. (2016) (2)
- ELISPOT and functional T cell analyses using HLA mono-specific target cells. (2009) (2)
- OC-038 Specific Microrna Markers are Identified in Bile in Pancreatic Ductal Adenocarcinoma (2013) (2)
- HIV-1 Step Study (2009) (2)
- Use of genetic variants of LMTK3 to predict tumor recurrence in female localized gastric adenocarcinoma. (2012) (2)
- Can pharmacogenomics guide effective anticancer therapy in pancreatic ductal adenocarcinoma? (2012) (2)
- The efficacy of tacrolimus and sirolimus in heavily pre-treated unresectable thymic malignancies. (2013) (2)
- Complications of therapy and a diagnostic dilemma case. Case 1. Radiation maculopathy following treatment of nasopharyngeal carcinoma. (2003) (2)
- Role of miRNAs in the response to anticancer therapy. (2012) (2)
- Lessons to Europe from China for cancer treatment during the COVID-19 pandemic (2020) (2)
- No-touch isolation surgical technique reduces dissemination of circulating tumor cells in patients with pancreatic cancer (2013) (2)
- COVID‐19 and the risk to cancer patients in China (2020) (2)
- A pregnant breast lump (2000) (2)
- HIV-associated Castleman's disease: from case reports to evidence. (2007) (2)
- Modeling the Prognostic Impact of Circulating Tumor Cells Enumeration in Metastatic Breast Cancer for Clinical Trial Design Simulation (2022) (2)
- A single-center cohort experience of raltegravir in salvage patients failing therapy. (2010) (2)
- A tale of three Hs: HPV, HIV & HAART. (2006) (2)
- KSHV specific CTLs target Darwinian positively selected autologous epitopes within ORF-K1 (2003) (2)
- A pyroptosis‐related lncRNA signature in bladder cancer (2022) (2)
- Electrotherapy: enlightening modern medicine. (2014) (2)
- Rituximab therapy for HIV-associated multicentric Castleman disease (2010) (2)
- Prevalence of ctDNA in early screen-detected breast cancers using highly sensitive and specific dual molecular barcoded personalised mutation assays. (2021) (2)
- Raising a glass of red wine against cancer, or not? (2012) (1)
- Changes in [18F]Fluorothymidine Pharmacokinetics Following Capecitabine Treatment in Human Breast Cancer Detected by Positron Emission Tomography. (2009) (1)
- Successful Treatment with Ensartinib After Alectinib-induced Hyperbilirubinemia in ALK-Positive NSCLC (2021) (1)
- Lessons to Europe from China for cancer treatment during the COVID-19 pandemic (2020) (1)
- Abstract P6-17-03: 24 months results from a double-blind, randomized phase III trial comparing the efficacy and safety of neoadjuvant then adjuvant trastuzumab and its biosimilar candidate CT-P6 in HER2 positive early breast cancer (EBC) (2019) (1)
- Modelling of Nanoparticle Distribution in a Spherical Tumour during and Following Local Injection (2022) (1)
- MicroRNA-mRNA interactions controlled by TGF-b (2020) (1)
- 805 Safety and emerging evidence of immune modulation of the live biotherapeutic MRx0518 in the neoadjuvant setting for patients awaiting surgical removal of solid tumours (2020) (1)
- Abstract GS4-08: Clinical utility of repeated circulating tumor cell (CTC) enumeration as early treatment monitoring tool in metastatic breast cancer (MBC) - a global pooled analysis with individual patient data (2021) (1)
- LMTK3 inhibition affects microtubule stability (2021) (1)
- PARP inhibitors in BRCA 1-/ BRCA 2-associated and triple-negative breast cancers “ PARP inhibitors induce the generation of unrepaired DNA single-strand breaks , which appear to cause the accumulation of double-strand breaks . . . ” (1)
- No evidence for a viral association or aetiology in pancreatic cancer. (2010) (1)
- Risk and Incidence of Infection with Bevacizumab in Non-Small-Cell Lung Cancer Patients: A Meta-Analysis (2022) (1)
- Combining luteinising hormone releasing hormone agonists and aromatase inhibitors in breast cancer. (2010) (1)
- Use of insulin-like growth factor (IGF) pathway polymorphism IGF1R_rs2016347 to predict tumor recurrence in estrogen receptor-positive breast cancer patients. (2011) (1)
- Hide and seek: tell-tale signs of breast cancer lurking in the blood (2012) (1)
- Reply to letter to the editor: baricitinib and toxicity is a rare occurrence (2020) (1)
- Comparison of two targeted ultra-deep sequencing technologies for analysis of plasma circulating tumour DNA in endocrine-therapy-resistant breast cancer patients (2021) (1)
- Correction: Distinct co-acquired alterations and genomic evolution during TKI treatment in non-small-cell lung cancer patients with or without acquired T790M mutation (2019) (1)
- Alternative splicing events in tumor immune infiltration in renal clear cell carcinomas (2022) (1)
- Improving outcomes in cholangiocarcinomas. (2011) (1)
- Dual immune checkpoint blockade for non-small cell lung cancer patients with PD-L1 high expression: calling an end? (2021) (1)
- The clinical significance of tumor infiltrating lymphoctyes in breast cancer: does subtype matter? (2012) (1)
- Reply to Z.S. Lalmahomed et al (2010) (1)
- Afatinib treatment in a lung adenocarcinoma patient harboring a rare EGFR L747P mutation (2022) (1)
- Imaging , Diagnosis , Prognosis Altered Tissue 3 ′-Deoxy-3 ′-[ 18 F ] Fluorothymidine Pharmacokinetics in Human Breast Cancer following Capecitabine Treatment Detected by Positron Emission Tomography (2009) (1)
- Cancer: Where were we, where are we, where are we going (2014) (1)
- Shark cartilage: has the popularisation of science failed? (2012) (1)
- Erlotinib or capecitabine with gemcitabine in pancreatic cancer? (2006) (1)
- Breast cancer: metastatic. (2002) (1)
- Combination antiretroviral therapy toxicities: a comparison between patients and health care professionals. (2011) (1)
- Rapid selection and archiving of mutation E157Q in HIV-1 DNA during short-term low-level replication on a raltegravir-containing regimen (2009) (1)
- Quality of evidence published in clinical journals: signs of change? (2006) (1)
- Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. (2004) (1)
- Methylation Changes in Neoplasia: Diagnostic and Therapeutic Implications (2008) (1)
- Artemisia: a divine dart against cancer? (2015) (1)
- Necrosis in melanoma metastases with treatment. (2001) (1)
- Opposing roles of dendritic cell subsets in HIV-1 infection (2006) (1)
- CD8 count measurement has independent prognostic significance in individuals with AIDS-Kaposi sarcoma (2007) (1)
- New drugs for old. (2005) (1)
- Thirty years of Oncogene (2018) (1)
- Pharmacokinetics of CT-P6 and reference trastuzumab by clinical factors in patients with HER2 positive early-stage breast cancer (EBC). (2018) (1)
- Rituximab induces long-term remissions in patients with HIV-associated multicentric Castleman's disease (2007) (1)
- HOT mutation screening in human glioblastomas (2015) (1)
- BIK (Bcl2-Interacting Killer) CpG methylation status as a potential predictive biomarker of relapsed/refractory multiple myeloma disease. (2010) (1)
- Translational review of AIDS-related Kaposi's sarcoma (2007) (1)
- Isolated conjunctival lymphoma metastasis from previous low grade non-Hodgkin’s lymphoma (2005) (1)
- Circulating microRNAs as dynamic biomarkers of response to treatment with FOLFIRINOX combination therapy in advanced pancreatic ductal adenocarcinoma (2017) (1)
- The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer (2008) (1)
- DNA methylation status of Smurf2 promoter in patients with multiple myeloma. (2016) (1)
- Receptor-based predictors of response in breast cancer. (2009) (1)
- A new prognostic index for systemic AIDS-related lymphoma (2005) (1)
- AIDS-Related Pathology (2011) (1)
- Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivo. (2004) (1)
- What’s the (end) point of cancer vaccines? (2006) (1)
- A comparison of the CD 4 response to antiretroviral regimens in patients commencing therapy with low CD 4 counts (2004) (1)
- HIV-associated primary lung cancer (LC) in the era of highly active antiretroviral therapy (HAART): a multi-institutional collaboration (2010) (1)
- Burkitt's lymphoma and previous AIDS-defining illnesses are not prognostic factors in AIDS-related non-Hodgkin's lymphoma. Authors' reply (2005) (1)
- The influence of HAART on HIV-associated primary cerebral lymphoma: Declining incidence and improving survival. (2006) (0)
- New concepts in anti-HIV therapies (2006) (0)
- Correction to: LMTK3 inhibition affects microtubule Stability (2021) (0)
- Radiation recall pneumonitis triggered by an immune checkpoint inhibitor following re-irradiation in a lung cancer patient: a case report (2022) (0)
- HIV-1-infected individuals Conservation of unique cell-surface CD antigen mosaics in (2010) (0)
- Profiling circulating tumour cells and cell free DNA together in metastatic colon cancer (2021) (0)
- SOME POSSIBLE CONTRIBUTIONS OF RADIOISOTOPES IN MEETING EMERGENT AFRICA'S BASIC NEEDS. (1969) (0)
- Abstract LB-8: Liquid chromatography - mass spectrometry proteomics to monitor the activity of multiple phosphorylation signaling pathways in cancer (2012) (0)
- 1158PROLE OF MICRORNA AS BIOMARKERS IN SMALL BOWEL NEUROENDOCRINE TUMOURS. (2014) (0)
- Melphalan and whole-blood stem cell reinfusion in castration-resistant prostate cancer (CRPC): A phase I/II study. (2011) (0)
- P65Myocardial miR-30 down-regulation caused by doxorubicin alters the beta-adrenergic system and mitochondrial death pathways (2014) (0)
- Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway (2014) (0)
- Neurolymphomatosis of multifocal peripheral nerve involvement: a case report. (2021) (0)
- multicentric Castleman disease Rituximab as retreatment for rituximab pretreated HIV-associated (2012) (0)
- The germline of the malaria mosquito produces abundant miRNAs, endo-siRNAs, piRNAs and 29-nt small RNAs (2015) (0)
- Is there any banding system in the clinical fellow salary? (2004) (0)
- PATHOGENESIS AND IMMUNITY-Kaposi’s Sarcoma-Associated Herpesvirus Cytatoxic T Lymphocytes Recognize and Target Darwinian Positively Selected Autologous K1 Epitopes (2003) (0)
- The microrna processing endoribonuclease dicer has altered expression in pancreatic ductal adenocarcinoma and prognostic implications (2015) (0)
- OTT_A_321965 4321..4328 (2021) (0)
- The anatomic localization of circulating tumor cells and the immediate impact of surgery and radiofrequency ablation. (2009) (0)
- KSHV as a model of the host-pathogen equilibrium. (2004) (0)
- HIV Infection and Esophageal Cancer—Reply (2010) (0)
- Changes in patient-reported outcomes in women with breast cancer in a multicenter double-blind randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms (AIMSS). (2012) (0)
- Impact of COVID-19 on Breast Cancer Treatment: A Tertiary Referral Centre Experience (2021) (0)
- Abstract 64: Identification of novel kinases involved in Estrogen receptor-α (ERα) signalling and the development of endocrine resistance in breast cancer (2012) (0)
- Genetic variants of kinases suppressors of ras (KSR1) to predict survival in patients with ER-alpha positive metastatic breast cancer. (2012) (0)
- Abstract P6-04-15: The involvement of LMTK3 in endocrine resistance is mediated via multiple signaling pathways (2012) (0)
- Abstract P6-07-03: Genetic heterogeneity revealed by targeted exome sequencing in advanced triple-negative breast cancer (2016) (0)
- Gene editing in the context of an increasingly complex genome (2018) (0)
- Shedding of bevacizumab in tumour cells-derived extracellular vesicles as a new therapeutic escape mechanism in glioblastoma (2018) (0)
- O1–094VALIDATION OF A NEW EPIGENETIC-BASED PROGNOSTIC BLOOD TEST TO PREDICT PROSTATE CANCER AGGRESSIVENESS (2013) (0)
- Prognostic value of lemur tyrosine kinase-3 (LMTK3) polymorphism in Japanese (J) patients (PTS) with localized gastric adenocarcinoma (GAC). (2012) (0)
- Correction to: LMTK3 inhibition affects microtubule Stability (2021) (0)
- Comparison of phenomics and cfDNA in a large breast screening population: the Breast Screening and Monitoring Study (BSMS) (2023) (0)
- Six-Year Survival Outcomes for Patients with HER2-Positive Early Breast Cancer Treated with CT-P6 or Reference Trastuzumab: Observational Follow-Up Study of a Phase 3 Randomised Controlled Trial. (2023) (0)
- MicroRNAs as Bile-Based Biomarkers in Biliary-Tract Cancers (2017) (0)
- A dynamic and prognostic interplay between KSR1, p53 and BRCA1 in breast cancer (2018) (0)
- Non cutaneous AIDS-associated Kaposi's sarcoma. (2006) (0)
- What is the average week for a clinical oncologist like? (2005) (0)
- Castrate‐resistant prostate cancer: the future of antiandrogens (2014) (0)
- Abstract 2670: Genetic variants in human epidermal growth factor receptor (HER) family gene predict tumor recurrence in breast cancer (2012) (0)
- Radiological imaging in the context of HIV infection: size of the lesion is not everything. (2008) (0)
- Phospho-proteomic analysis of pancreatic cancer indicates activation status of drug targets and likelihood of recurrence (1954) (0)
- Genomic instability in pre-neoplastic colonic lesions (2013) (0)
- Correction to: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth (2021) (0)
- A three-microRNA signature for predicting survival in pancreatic cancer (2012) (0)
- 176P Breast cancer treatment during the first wave of the COVID-19 pandemic at a UK centre (2021) (0)
- Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy (2018) (0)
- Abstract 5268: The expression of lemur tyrosine kinase-3 in high grade pediatric tumors (2014) (0)
- A microRNA meta-signature for pancreatic ductal (2014) (0)
- Abstract LB-339: Mutation analysis of cell-free DNA captures heterogeneity of individual circulating tumor cells in metastatic breast cancer (2016) (0)
- Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy (2017) (0)
- Breast cancer (metastatic). (2003) (0)
- Corrigendum to "A novel and validated prognostic index in hepatocellular carcinoma: The Inflammation Based Index (IBI)". (2016) (0)
- Abstract #LB-305: Genome wide screen of estrogen receptor-\#945; regulated microRNAs reveals a negative autoregulatory feedback loop (2009) (0)
- Breast cancer (metastatic). (2005) (0)
- Breast cancer: metastatic. (2002) (0)
- Multicenter S tudy o f H uman I mmunodeficiency Virus-Related G erm C ell T umors (2003) (0)
- P077 SMAD7 shows a biphasic expression pattern during progression of ulcerative colitis-associated colorectal cancer (2019) (0)
- The use of HRT in patients with breast cancer: yes, no, or sometimes? (2000) (0)
- Intermittent left bundle branch block ( LBBB ) as a clinical manifestation of myocardial contusion after blunt chest trauma (2005) (0)
- Abstract 4316: A dynamic interplay of KSR1, p53 and BRCA1 in breast cancer. (2013) (0)
- The increasing incidence of HIV-associated multicentric Castlemans disease (2008) (0)
- Abstract 1606: Global mapping of tyrosine kinase signalling in breast cancer by combined use of RNAi and SILAC quantitative proteomics (2014) (0)
- Cholesterol emboli syndrome (1995) (0)
- Chilli-too hot to handle? (2017) (0)
- A Lung Cancer Patient Harboring a Rare Oncogenic EGFR Exon 20 V786M Mutation Responded to a Third-Generation Tyrosine Kinase Inhibitor: Case Report and Review of the Literature (2022) (0)
- Autologous K 1 Epitopes Target Darwinian Positively Selected Cytotoxic T Lymphocytes Recognize and Kaposi ' s Sarcoma-Associated Herpesvirus (2003) (0)
- Highlights from the latest articles in breast cancer pharmacogenomics. (2012) (0)
- infected individuals - Conservation of unique cell-surface CD antigen mosaics in HIV-1 (2013) (0)
- Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients (2022) (0)
- A comparison of patients' attitudes to antiretroviral toxicities between the UK and Uganda. (2011) (0)
- Running title : CTCs and staging in MBC (2018) (0)
- PTU-083 Biliary Microrna Markers in Bile Aid the Diagnosis of Cholangiocarcinoma at ERCP (2013) (0)
- Review for "Genome‐wide DNA methylation profiling and identification of potential pan‐cancer and tumor‐specific biomarkers" (2021) (0)
- 778 Botensilimab, a novel innate/adaptive immune activator, plus or minus balstilimab (anti-PD-1) in “cold” and I-O refractory metastatic solid tumors (2022) (0)
- Genetic variants and response to cancer treatments (2015) (0)
- Identification of an immune gene-associated prognostic signature in patients with bladder cancer (2022) (0)
- Abstract 185: Role of phosphorylation in Lmtk3 activation and its contribution in breast cancer progression (2016) (0)
- A Prediction Model Using Alternative Splicing Events and the Immune Microenvironment Signature in Lung Adenocarcinoma (2021) (0)
- Phospho-proteomic analysis of pancreatic cancer indicates activation status of drug targets and may predict time of recurrence (1954) (0)
- BRCA1 mutations and luminal-basal transformation (2013) (0)
- Impact of Routine Use of CDK4/6 Inhibitor Therapy on Breast Cancer Outpatient Clinic Workload and Patient Experience (2019) (0)
- AIDS-related cancers, Part II: Systemic and cerebral lymphomas (2006) (0)
- Methylation reversal in high-grade B lymphoma cell lines and novel epigenetic changes conserved between immunocompetent and HIV-positive hosts. (2016) (0)
- MicroRNA expression profiles in pancreatic cystic tumors. (2010) (0)
- Abstract LB-226: Identification of novel kinases modulating ER: new therapeutic targets in breast cancer (2010) (0)
- Enhanced Sensitivity of Lymphoid Cells to Ethanol ADH Acetaldehyde Toxicity; Implications for GDEPT and Adoptive T Cell Therapy (2018) (0)
- 185P Long-term efficacy of trastuzumab biosimilar CT-P6 in patients with HER2-positive early breast cancer: 6-year survival analysis of phase III study results (2022) (0)
- Patient-derived xenografts effectively capture patient clinical responses to oncology therapy (2016) (0)
- Longitudinal assessment of systemic steroid therapy on hyperinflammatory endothelial biomarker profiles and serology responses of COVID-19 patients (2022) (0)
- Companion Diagnostics and Biomarkers Prognostic Role of Lemur Tyrosine Kinase-3 Germline Polymorphisms in Adjuvant Gastric Cancer in Japan and the United States (2013) (0)
- Approaches for therapeutic vaccination in HIV infection. (2005) (0)
- The Inhibitory Properties of a Novel, Selective LMTK3 Kinase Inhibitor (2023) (0)
- Gut Infection in HIV: Past, Present and Future (2003) (0)
- Randomised controlled trial investigating the efficacy and mechanism of healing of two different autologous skin grafts for wound healing ( EPIGRAAFT ) (2017) (0)
- Abstract 3794: The role of LMTK3 in breast cancer cell growth and invasion. (2013) (0)
- Abstract P4-04-06: Study of the mutational landscape of normal and pregnant breast to predict pregnancy-associated breast cancer risk (2019) (0)
- Choline-Positron Emission R ography and Effect of Trastuzumab (2010) (0)
- Methylation Status of SMURF2 and Correlation with Clinical Parameters in Patients with Multiple Myeloma (2008) (0)
- Bella and the blood sample (2003) (0)
- Abstract P4-03-02: Stromal kinome screening identifies a novel regulatory kinase implicated in fibroblast-mediated progression of invasion in triple negative breast cancer tumours (2017) (0)
- Indeterminate pulmonary nodules in breast cancer: Clinical significance and management (2008) (0)
- Recovery of cellular immunity following chemotherapy for AIDS related non Hodgkin's lymphoma (2008) (0)
- Correction to: A cell-cycle signature classifier for pan-cancer analysis (2021) (0)
- The role of LMTK3 in chromatin remodeling and transcriptional regulation (2015) (0)
- Abstract P2-08-08: Circulating tumor cells count-based nomograms to predict survival of metastatic breast cancer patients: Results from the European pooled analysis (2016) (0)
- The role of LMTK 3 in chromatin remodeling and transcriptional regulation (2015) (0)
- Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients? (2018) (0)
- Abstract 4213: Evaluation of LMTK3 expression and tumor phenotype in estrogen-dependent colorectal cancer (2014) (0)
- Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas (2018) (0)
- OTT_A_310756 3409..3415 (2021) (0)
- Oncology and pharmacogenetics in 2007. (2007) (0)
- Hotspots during Leukemic Transformation of B Cell Precursors Graphical (2017) (0)
- Surgery in combination with peptide receptor radionuclide therapy is effective in metastatic neuroendocrine tumors and is definable by blood gene transcript analysis. (2017) (0)
- Anti-retroviral treatment regimens and immune parameters in the prevention of systemic HIV-related non-Hodgkin's lymphoma. (2004) (0)
- Genetic variants of kinases suppressors of ras in KRAS-BRAF wild-type metastatic colorectal cancer patients treated with cetuximab and irinotecan. (2012) (0)
- Analysis of BCR ABL1 Tyrosine Kinase Domain Mutations In Primitive Chronic Myeloid Leukemia Cells Identifies a Unique Mutator Phenotype (2010) (0)
- New therapies for hepatitis infection (2006) (0)
- [11C]Choline-PET imaging of breast cancer. (2016) (0)
- Whole exome next-generation sequencing of triple-negative breast cancers and rare tumours to reveal novel molecular pathways and therapeutic targets for personalized therapy. (2015) (0)
- Multiscale Modelling of Nanoparticle Distribution in a Realistic Tumour Geometry Following Local Injection (2022) (0)
- gene silencing has an anti malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural (2019) (0)
- Crystals and cancer: good vibrations or bad intentions? (2014) (0)
- Tumor volume analysis in clinical oncology. (2009) (0)
- Correction: KSR1 regulates BRCA1 degradation and inhibits breast cancer growth (2021) (0)
- Design and reporting of phase III oncology trials with prospective biomarker validation. (2022) (0)
- Breast cancer--22nd annual symposium. 8-11 December 1999, San Antonio, TX, USA. (2000) (0)
- How is the role of clinical fellow different from that of senior house officer? (2004) (0)
- The identification of new tumour suppressor micrornas epigenetically silenced in drug resistant cancer cells (2008) (0)
- The many-faced KSR1: a tumor suppressor in breast cancer (2015) (0)
- Abstract P3-06-31: Patient-derived xenografts accurately predict patient response in breast cancer patients (2015) (0)
- Studs, the Ordernet and peer review (1998) (0)
- Global kinome silencing combined with 3D invasion screening of the tumor microenvironment identifies fibroblast-expressed PIK3Cδ involvement in triple-negative breast cancer progression (2019) (0)
- Response to Cottu, Bozec, Basse, and Paoletti. (2021) (0)
- Breast cancer (metastatic). (2007) (0)
- Developments in paediatric cancer care throughout the COVID-19 pandemic: Lessons from China (2022) (0)
- Breast cancer (non-metastatic). (2007) (0)
- Abstract P1-04-04: KSR1 is involved in functional interaction between p53 and BRCA1 and is an independent predictor of overall survival in breast cancer (2012) (0)
- Abstract S3-7: Kinome Screening for Regulators of Estrogen Receptor Identifies a Novel Kinase as a New Therapeutic Target in Breast Cancer (2010) (0)
- Harms of cigarette smoking: call to increase knowledge among children (2018) (0)
- 1573PDPATIENT-DERIVED XENOGRAFTS ACCURATELY CAPTURE CLINICAL RESPONSES TO TREATMENT. (2014) (0)
- Abstract PD5-10: Mutational burden of the normal breast during age and pregnancy (2021) (0)
- Abstract 1617: Quantification of pancreatic cancer proteome & phosphorylome: Indicates molecular events likely contributing to cancer & activation status of drug targets (2014) (0)
- Clots and cancer. (2006) (0)
- A meta-analysis of microRNAs with prognostic significance in pancreatic ductal adenocarcinoma (2014) (0)
- Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘ (2013) (0)
- Snk/Plk2 CpG methylation in patients with multiple myeloma. (2009) (0)
- AIDS-related cancers, Part I: Kaposi's sarcoma and cervical cancer (2005) (0)
- Breast cancer (metastatic). (2004) (0)
- Snk/Plk2 Methylation Is a Frequent Event in Patients with Multiple Myeloma (2008) (0)
- Expert's Comments - Stress in the workplace amongst medicalprofessionals (2007) (0)
- Conserved epigenetic changes in sporadic and HIV-associated high-grade B-cell lymphomas (2007) (0)
- Pegylated liposomal doxorubicin (Caelyx TM )i n recurrent ovarian cancer (2002) (0)
- Fulminant diabetic ketoacidosis complicating nivolumab immunotherapy (2017) (0)
- Contents Vol. 122, 2012 (2012) (0)
- Host immunogenetics and control of human herpesvims-8 infection. Commentary (2006) (0)
- Artificial antigen-presenting cells: a natural approach to chronic viral infection? (2007) (0)
- Probiotics and cancer: ready for meal time? (2015) (0)
- TGF-ß induces miR-100 and miR-125b but blocks let-7a to promote pancreatic cancer (2020) (0)
- BIK (Bcl2-Interacting Killer) CpG Methylation Status in Multiple Myeloma Patients: a Potential Predictor of Relapsed/Refractory Disease. (2009) (0)
- KSR1 gene polymorphism in mCRC patients treated with first-line FOLFIRI and bevacizumab. (2012) (0)
- HBV and lymphoma: HIV matters (2011) (0)
- What's new in cancer and HIV? (2006) (0)
- Cancer Risk and Sedative Hypnotics (2018) (0)
- P975 DYNAMIC CHANGES OF THE INFLAMMATION BASED INDEX (IBI) AS A PREDICTOR OF MORTALITY FOLLOWING TRANS-ARTERIAL CHEMOEMBOLIZATION FOR HEPATOCELLULAR CARCINOMA (2014) (0)
This paper list is powered by the following services:
Other Resources About Justin Stebbing
What Schools Are Affiliated With Justin Stebbing?
Justin Stebbing is affiliated with the following schools:
